Tailin Pharmaceuticals (01011.HK): Wu Jingjie appointed as Chief Executive Officer.

Translated to Wisdom Finance and Economics APP News, Tailing Pharmaceuticals (01011.HK) announced that Mr. Zhang Bozhi has resigned from the position of CEO, in order to invest more time in personal and other matters, effective from July 3, 2026. Mr. Zhang Bozhi will no longer hold any position in the company or any of its subsidiaries after his resignation.